Day 2 Highlights – What to watch for on Thursday, July 1
The 6th World Psoriasis and Psoriatic Arthritis Conference (WPPAC) 2021 continues with a deeper delve into the conference theme of Connected, informed, and united to improve multidisciplinary care for people with psoriasis & psoriatic arthritis. Day 2 takes advantage of the innovative on-line format this year to bring together experts located around the world for live, interactive discussions. Day 2 also features two more keynote lectures, oral abstracts, all-new topics in the Complementary Program, and a special joint session by conference organizers IFPA and the Group for Research and Assessment of Psoriatic Arthritis (GRAPPA).
What to watch on Day 2: Thursday, July 1
Interactive discussion session
This session’s topic is the role of doctor/patient communication in improving outcomes and wellbeing. It includes lectures from patient expert Silvia Fernandez Barrio, Professor Katy Leung, and Dr. Christian Greis. In an innovative online format featuring live participation from speakers located around the world, these lectures are followed by a live interactive discussion.
Professor Christine Bundy from the UK speaks and answers questions about self-responsibility and self-management – encouraging lasting behaviour change in patients with psoriasis/psoriatic arthritis.
Professor Dirk Elewaut from Belgium speaks and answers questions on the hot topic of the general impact of the microbiome in chronic, inflammatory disease.
Joint IFPA/GRAPPA session on palmoplantar pustulosis
This collaborative session features patient testimonials followed by lectures from GRAPPA on the particular features, challenges, and recent research on palmoplantar pustulosis.
The Complementary Program is primarily directed at allied health professionals, non-specialists, patient leaders, and industry representatives. It is broken up into two sessions on Day 2, both on the theme of the day: Lifestyle, dealing with daily life problems, latest research and mental health.
Session 3 of the Complementary Program features lectures on psoriatic arthritis for the dermatologist from Dr. Alan Menter; alcohol and food systems – the latest in the prevention policy landscape for the psoriasis community from NCD Alliance’s Lucy Westerman; lifestyle intervention programs from Professor Luigi Naldi; and the relevance of the gut microbiome to psoriasis from Professor Ignacio Dei-Cas. The session ends with a live Q&A.
Session 4 of the Complementary Program kicks off with 2 talks with a focus on mental health: “Psychotherapy and psoriasis” from Professor Anthony Bewley and “Making use of placebo effects in clinical care for the well-being of psoriasis patients: role of cognitive behavioral therapy” from Professor Andrea Evers Leiden. These are followed by an interactive workshop on support group sessions and functioning led by advocates Kathleen Gallant, Silvia Fernandez Barrio, and Paul Mendoza. Speakers and panelists are also be available for a live Q&A.
Oral abstract presentations
Day 2 features findings from two major abstracts:
Changes in Patient Perceptions of Psoriatic Arthritis From 2012 to 2020: Results From the UPLIFT Survey presented by Dr. Alexis Ogdie
Psoriasis and Psoriatic Arthritis in Transgender Patients on Hormone Therapy: A Retrospective Comparative Cohort Study presented by Julia Gao
Poster abstracts are available online from Wednesday, June 30. Don’t forget to stop by the virtual abstract hall to learn about the very latest research on psoriasis and psoriatic arthritis.
Join us tomorrow for Day 3!
About the 6th World Psoriasis & Psoriatic Arthritis Conference 2021
Conference name: 6th World Psoriasis & Psoriatic Arthritis Conference 2021
Theme: “Connected, informed, and united to improve multidisciplinary care for people with psoriasis & psoriatic arthritis”
Dates: June 30 – July 3, 2021
Venue: Virtual Conference broadcast from Stockholm, Sweden
Target group: Dermatologists, rheumatologists and general practitioners and allied health professionals with an interest in psoriasis and psoriatic arthritis
Twitter: @PsoriasisIFPA, #WPPAC21
About IFPA – Global leader in fighting psoriatic disease.
IFPA is a non-profit organization speaking up for 60 million people living with psoriatic disease worldwide. Together, we are determined to build a future where all people living with psoriatic disease enjoy good health and wellbeing, free from stigma and preventable disability and comorbidities.
You can read more about IFPA’s activities on ifpa-pso.com.
Camille Lancelot, IFPA Communications Manager.
Telephone: +46 73 961 15 65